登录
注册
您所在的位置:首页>>报告>>报告详情

Presentation of the French Plan for Genomic Medicine 2025

法国政府发布基因组医学计划2025

【作       者】:

{{d.作者}}

【机       构】: 法国政府
【承研机构】:

【英文机构】: Government of France?
【原文地址】: http://presse.inserm.fr/en/presentation-of-the-french-plan-for-genomic-medicine-2025/24328/
【发表时间】:

2016-08-13

摘要

Probably the most widely repeated claim in the debate over global warming is that “97 percent of scientists agree” that climate change is man-made and dangerous. This claim is not only false, but its presence in the debate is an insult to science.As the size of recent reports by the alarmist Intergovernmental Panel on Climate Change (IPCC) and its skeptical counterpart, the Nongovernmental International Panel on Climate (NIPCC) suggest, climate science is a complex and highly technical subject, making simplistic claims about what “all” or “most” scientists believe necessarily misleading. Regrettably, this hasn’t prevented various politicians and activists from proclaiming a “scientific consensus” or even “overwhelming scientific consensus” that human activities are responsible for observed climate changes in recent decades and could have “catastrophic” effects in the future.The claim that “97 percent of scientists agree” appears on the websites of government agencies such as the U.S. National Aeronautics and Space Administration (NASA, 2015) and even respected scientific organizations such as the American Association for the dvancement of Science (AAAS, n.d.), yet such claims are either false or meaningless.

Genomic medicine is a reality: it is already transforming the manner in which a disease is prevented, diagnosed and treated, and how its progression is predicted. It is a highly competitive area internationally, with every country now hoping to introduce genomic medicine in its care pathway, develop an industrial sector and attract scientific talent in order to consolidate its strengths. To develop this Plan, the Aviesan alliance gathered together for a year institutional representatives and cross-sectional authorities from the research, health and industrial sectors, health and research agencies, ministerial headquarters, industries represented by ARIIS (Alliance for Research and Innovation in Health Industries), CNAM (National Health Insurance Fund), HAS (French National Authority for Health), CGI and école d’économie de Toulouse (Toulouse School of Economics).

标签: {{b}}
展开

相关报告